University Of Leipzig
Clinical trials sponsored by University Of Leipzig, explained in plain language.
-
Shorter treatment for tough leukemia shows promise in pilot study
Disease control OngoingThis study tests a new way of giving two drugs (venetoclax and azacitidine) to adults with acute myeloid leukemia (AML) who are too old or sick for standard chemotherapy. Instead of the usual 7 days of azacitidine, this approach uses only 5 days per cycle to reduce side effects l…
Phase: PHASE2 • Sponsor: University of Leipzig • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New study aims to simplify diagnosis of hidden heart failure
Diagnosis OngoingThis study looks at better ways to diagnose a type of heart failure called HFpEF in people who have shortness of breath but no clear cause. Researchers will compare simple tests to the standard invasive procedure to see which ones work best. The goal is to make diagnosis easier a…
Sponsor: University of Leipzig • Aim: Diagnosis
Last updated May 11, 2026 20:49 UTC
-
Heart procedure put to the test: sham surgery reveals truth about AF treatment
Symptom relief OngoingThis study compares a standard heart procedure called pulmonary vein isolation (PVI) to a fake (sham) procedure in 262 people with atrial fibrillation. The goal is to see if the real procedure actually reduces symptoms and improves quality of life more than the placebo effect. Pa…
Phase: NA • Sponsor: University of Leipzig • Aim: Symptom relief
Last updated May 17, 2026 05:53 UTC
-
New registry digs into statin side effects affecting millions
Knowledge-focused OngoingThis study follows 1,000 adults with dyslipidemia who have had bad reactions to at least two different statins. Researchers will track how doctors adjust treatments, changes in cholesterol levels, and quality of life over time. The goal is to better understand statin intolerance …
Sponsor: University of Leipzig • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Smartwatches vs. implants: a cheaper way to catch hidden stroke causes?
Knowledge-focused OngoingThis study tests whether a smartwatch (Apple Watch or PulseOn) can detect hidden atrial fibrillation (AF) in 84 stroke survivors who already have an implanted heart monitor. Participants wear the watch for 12 weeks, and the watch alerts them if it senses an irregular pulse. The g…
Phase: NA • Sponsor: University of Leipzig • Aim: Knowledge-focused
Last updated May 11, 2026 20:47 UTC